Evidence map›Paper›PMID 25298579›Full record

Observational studyIndian journal of pharmacology

A study of use of fixed dose combinations in Ahmedabad, India.

Jayeshbhai Dineshchandra Balat, Anuradha M Gandhi, Prakruti P Patel, Ram K Dikshit

Abstract readObservational Study
In one paragraph

Observational study in Indian journal of pharmacology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Herbal Fixed Dose Combinations in Nepal: Growing Concerns in a Developing Country.Journal of clinical and diagnostic research : JCDR · 2016
    Article
  2. Assessment of Rationality of Fixed Dose Combinations Approved in CDSCO List.Journal of clinical and diagnostic research : JCDR · 2016
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jayeshbhai Dineshchandra BalatDepartment of Pharmacology, M. P. Shah Medical College, Jamnagar, Gujarat, India.
Anuradha M GandhiDepartment of Pharmacology, B. J. Medical College, Ahmedabad Gujarat, India.
Prakruti P PatelDepartment of Pharmacology, B. J. Medical College, Ahmedabad Gujarat, India.
Ram K DikshitDepartment of Pharmacology, B. J. Medical College, Ahmedabad Gujarat, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe aim of this study was to evaluate the pattern of fixed dose combinations (FDCs) in Ahmedabad, a city in western part of India. MATERIALS AND

methodsOver a period of 24 months, prescriptions were collected from 24 pharmacy stores across 6 zones of Ahmedabad city. The information was recorded in pre-formed Data Record Form after written consent from the patients (or relative (s) of the patients). The pattern of use of FDC, rationality and seasonal variation in their use were analyzed. At the end of study, results were analyzed using Chi-square test.

resultsOut of the total 1170 prescriptions, 941 (80.3%) contained 1647 FDC formulations. The average number of FDCs prescribed was 1.41 ± 1.04 (mean ± SD). The FDCs were more frequently prescribed in the age group of 31 to 40 years (23.7%) and in males (54.4%). FDCs were most commonly prescribed by oral route (92.7%). As per drug category analysis, a higher number of FDCs containing nutritional supplements (20.2%), and those for CNS (18.1%) complaints were prescribed. A seasonal analysis showed that FDCs were commonly prescribed for respiratory complaints (23.4%), central nervous system (CNS) complaints (20.3%) and as nutritional supplements (22.4%) in winter, monsoon and summer months, respectively. Only 5.8%, 9.8% and 10.9% FDCs prescribed were included in WHO (2010), National (2011) and Gujarat State (2011) Essential Medicines Lists (EML), respectively (P < 0.0001). Irrational FDCs that are banned or FDCs containing irrational active ingredients were 1343 (81.5%) and 203 (12.3%), respectively.

conclusionFDCs are widely prescribed with seasonal influence in their use. FDCs containing banned or controversial ingredients are prescribed widely.

Indexed as

AdultCross-Sectional StudiesDrug CombinationsFemaleHumansInappropriate PrescribingIndiaMaleMiddle AgedPractice Patterns, Physicians'Prescription DrugsProspective StudiesSeasonsDrug CombinationsPrescription DrugsBanned FDCsFixed dose combinationsirrational FDCs

Identifiers

PMID25298579
PMCPMC4175886

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.